CTLA4 and neoplasm: Moreover, preclinical studies found that radiation delivered as single high dose of 20 Gy could impair tumour immunogenicity, whereas fractionated radiotherapy could stimulate anti‐tumour immunity and demonstrated effective abscopal responses when combined with anti‐CTLA‐4 antibody.65, 66